EcoDrugPlus

Prostaglandin E Receptor 3

Ensembl ID : ENSSMAG00000002690
Gene Symbol: PTGER3
3 Cross references
194 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) A

Ensembl ID : ENSSMAG00000003445
Gene Symbol: PTGER4A
3 Cross references
202 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) B

Ensembl ID : ENSSMAG00000010391
Gene Symbol: PTGER4B
3 Cross references
201 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSSMAG00000002469
Gene Symbol: LOC118289260
3 Cross references
164 Possible Orthologues:

Prostaglandin F Receptor (Fp)

Ensembl ID : ENSSMAG00000007633
Gene Symbol: PTGFR
3 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSSMAG00000014044
Gene Symbol: PTGIR
2 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSSMAG00000008073
Gene Symbol: PTGS1
2 Cross references
212 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2b

Ensembl ID : ENSSMAG00000020788
Gene Symbol: PTGS2B
3 Cross references
214 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSSMAG00000000257
Gene Symbol: PSMA1
2 Cross references
270 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSSMAG00000012319
Gene Symbol: PSMA3
3 Cross references
238 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSSMAG00000005090
Gene Symbol: PSMA4
2 Cross references
186 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSSMAG00000006628
Gene Symbol: PSMA5
2 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).